Twist Bioscience Corporation
Market Cap
$2.90B
P/E Ratio
-37.23
EPS
$-1.27
Dividend Yield
0.00%
52-Week Range
$23.30 — $57.88
Volume
915.92K
Avg Volume
1.28M
Beta
2.29
P/E (TTM)
-37.23
Forward P/E
—
PEG Ratio
-15.69
P/S (TTM)
7.11
P/B (TTM)
6.08
P/FCF
-55.69
EV/EBITDA
-57.35x
EV/Sales
—
ROE (TTM)
-0.17%
ROA (TTM)
-0.12%
ROIC
-0.06%
Gross Margin
0.52%
Operating Margin
-0.34%
Net Margin
-0.29%
Debt/Equity
0.40
Current Ratio
3.78
EPS Growth (YoY)
+0.06%
Revenue Growth (YoY)
+0.13%
EPS Growth (3Y)
+0.25%
EPS Growth (5Y)
+0.12%
Sales Growth (3Y)
+0.23%
Sales Growth (5Y)
+0.34%
EPS Est (This Year)
$-1.80
EPS Est (Next Year)
$-1.20
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$3.24
Strong Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $48.25(2.1% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
-57983
Outstanding Shares
61.31M
Float
58.50M
Free Float %
95.41%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
NASDAQ
IPO Date
2018-10-31
Employees
923
CEO
Emily Marine Leproust
Index Membership
—
Website
https://www.twistbioscience.com
Twist Bioscience Corporation (TWST) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $2.90B, a P/E ratio of -37.23, TWST is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare TWST against other stocks using dozens of fundamental and technical filters.
Twist Bioscience Corporation (TWST) has a trailing twelve-month (TTM) P/E ratio of -37.23. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Twist Bioscience Corporation (TWST) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Twist Bioscience Corporation (TWST) has a market capitalization of $2.90 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Strong Buy" rating on Twist Bioscience Corporation (TWST) with an average score of 1.50 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $48.25 implies 2.1% upside from the current price.